People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Armgo Pharma Inc | — | Pharmaceuticals | Pre-Seed | $1.0M | $47.3M | 2011 |
Karen A. Katen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Karen A. Katen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sapan Shah | 1 | 4 |
| Andrew Marks | 1 | 4 |
| Andrew A. Schiff | 1 | 3 |
| Alan A. Fuchsberg | 1 | 1 |
| Paul A. Marks | 1 | 1 |
| Kat A. Larson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.